{"symbol":"LLY","fiscalQuarter":"Q2-2022","reportDate":"2022-08-04","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q2-2022","postBrief":{"headline":"Eli Lilly Misses on EPS, Stock Down 2.56%","keyNumbers":[{"metric":"EPS","actual":"$1.25","expected":"N/A","surprise":"-30.67%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management acknowledged the challenges faced this quarter.","They emphasized a focus on long-term growth despite current setbacks."],"summary":"Management expressed concerns over recent performance but remains focused on future opportunities. They did not provide specific guidance for the upcoming quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Eli Lilly's earnings report showed a significant miss on EPS, which contributed to a 2.56% decline in stock price. The company did not provide revenue figures or guidance, leaving investors uncertain about future performance. The management's cautious tone suggests they are aware of the challenges ahead but are committed to long-term strategies.","metaDescription":"Eli Lilly (LLY) Q2 2022 earnings: EPS missed expectations. Stock down 2.56%. Full breakdown."}}